The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1

Genes and Development

Volumn 16, Issue 14, 2002, Pages 1839-1851

  Wilhelm, Dagmar ^a,b   Englert, Christoph ^a,c  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dax 1; Lhx9; Sex determination; Transcription factor; Transgenic mice; Zinc finger protein

Indexed keywords

GENE PRODUCT; HOMEODOMAIN PROTEIN; PROTEIN LHX9; PROTEIN WT1; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; FRASER SYNDROME; GENE ACTIVATION; GENE EXPRESSION; GENE INTERACTION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GONAD DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; SEX DETERMINATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 0037099299     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.220102     Document Type: Article

References (49)

1. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans
2. Targeted mutagenesis of the endogenous mouse Mis gene promoter: In vivo definition of genetic pathways of vertebrate sexual development
3. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo
4. Donor splice-site mutations in WT1 are responsible for Frasier syndrome
5. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
6. Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula
7. The LIM homeobox gene Lhx9 is essential for mouse gonad formation
8. A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies
9. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
10. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1
11. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene
12. WT1-More than a transcription factor?
13. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
14. Induction of p21 by the Wilms' tumor suppressor gene WT1
15. Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control
16. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
17. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione Stransferase
18. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant
19. Alternative splicing and genomic structure of the Wilms tumor gene WT1
20. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation
21. The Wilms tumor suppressor gene wt1 is required for development of the spleen
22. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases
23. Comparative localization of Dax-1 and Ad4BP/SF1 during development of the hypothalamic-pituitary-gonadal axis suggests their closely related and distinct functions
24. Structure and function of LIM domains
25. Dax-1 as one of the target genes of Ad4BP/SF1
26. Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?
27. The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation
28. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms
29. WT-1 is required for early kidney development
30. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
31. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation
32. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
33. The Wilms' tumor 1 gene: Oncogene or tumor suppressor gene?
34. YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb
35. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF1 in sex-specific gene expression
36. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product
37. Genes essential for early events in gonadal development
38. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
39. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour
40. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation
41. The transcriptional effect of WT1 is modulated by choice of expression vector
42. The WT1 Wilms' tumor suppressor gene: How much do we really know?
43. Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion
44. Mammalian sex determination: A molecular drama
45. Analysis of WT1 target gene expression in stably transfected cell lines
46. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1
47. Characterization of the promoter of SF1, an orphan nuclear receptor required for adrenal and gonadal development
48. Role of Ahch in gonadal development and gametogenesis